HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
SONN - Sonnet BioTherapeutics Holdings Inc - Stock Price Chart
TickerSONN [NASD]
CompanySonnet BioTherapeutics Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap13.14MEPS (ttm)-12.83
P/E-EPS this Y69.52%
Forward P/E-EPS next Y-
PEG-EPS past 5Y85.27%
P/S13.14EPS next 5Y-
P/B19.57EPS Q/Q-240.61%
Dividend-Sales Q/Q-
Insider Own1.22%Inst Own5.09%
Insider Trans0.00%Inst Trans74.16%
Short Float1.94%EarningsMay 20
Analyst Recom1.00Target Price20.00
Avg Volume44.93K52W Range1.08 - 10.02
May-01-25 09:00AM Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit (GlobeNewswire)
Apr-16-25 09:10AM Sonnet Releases Virtual Investor 'What This Means' Segment (GlobeNewswire)
Apr-04-25 09:00AM Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose (GlobeNewswire)
Apr-01-25 04:15PM Sonnet Announces Release of Corporate Update Video (GlobeNewswire) -5.22%
07:30AM Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. (GlobeNewswire)
Mar-26-25 09:05AM Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas (GlobeNewswire)
Mar-19-25 08:50AM Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein (GlobeNewswire)
Mar-11-25 08:45AM Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor Top 5 for '25 On-Demand Conference (GlobeNewswire)
Feb-26-25 09:00AM Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors (GlobeNewswire)
Feb-19-25 08:35AM Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates (GlobeNewswire)
AEBI - Aebi Schmidt Holding AG - Stock Price Chart
TickerAEBI [NASD]
CompanyAebi Schmidt Holding AG
CountrySwitzerland
IndustryFarm & Heavy Construction Machinery
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume-52W Range- - -
BGL - Blue Gold Ltd - Stock Price Chart
TickerBGL [NASD]
CompanyBlue Gold Ltd
CountryCayman Islands
IndustryGold
Market Cap909.53MEPS (ttm)0.07
P/E2006.03EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B683.73EPS Q/Q115.38%
Dividend-Sales Q/Q-
Insider Own50.79%Inst Own0.52%
Insider Trans0.00%Inst Trans-
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume117.39K52W Range4.00 - 114.99
Jun-30-25 04:10PM Blue Gold Limited Announces Acquisition Initiatives Following Successful Listing on Nasdaq (GlobeNewswire) -33.71% +73.67%
LIXT - Lixte Biotechnology Holdings Inc - Stock Price Chart
TickerLIXT [NASD]
CompanyLixte Biotechnology Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap5.42MEPS (ttm)-1.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.10%
P/S-EPS next 5Y-
P/B-EPS Q/Q33.51%
Dividend-Sales Q/Q-
Insider Own22.33%Inst Own11.18%
Insider Trans0.00%Inst Trans0.65%
Short Float0.21%Earnings-
Analyst Recom-Target Price-
Avg Volume243.27K52W Range0.64 - 3.00
Jul-02-25 04:05PM Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market (GlobeNewswire) +71.19%
Jul-01-25 04:15PM Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market (GlobeNewswire) +30.39%
Mar-31-25 08:30AM LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100 (GlobeNewswire)
Mar-27-25 08:30AM LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer (GlobeNewswire)
Mar-10-25 08:30AM New Findings Show how LIXTE's Lead Clinical Compound, LB-100, is Metabolized to its Active Form (GlobeNewswire)
Feb-25-25 08:30AM LIXTE Adds Northwestern University's Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer (GlobeNewswire) +15.36%
Feb-14-25 10:43AM Lixte Biotechnology announces closing of $1.05M registered direct offering (TipRanks)
Feb-13-25 10:35AM LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -17.65%
Feb-11-25 08:42AM LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -15.35%
Feb-10-25 05:00PM LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement (GlobeNewswire) -7.32%
DAIC - CID Holdco Inc - Stock Price Chart
TickerDAIC [NASD]
CompanyCID Holdco Inc
CountryUSA
IndustryInformation Technology Services
Market Cap226.35MEPS (ttm)-0.49
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1043.89%
Dividend-Sales Q/Q-
Insider Own95.87%Inst Own4.06%
Insider Trans0.00%Inst Trans-
Short Float0.04%Earnings-
Analyst Recom-Target Price-
Avg Volume56.54K52W Range2.03 - 75.00
Jun-23-25 07:00AM Dot Ai to Begin Trading on Nasdaq Stock Market (Business Wire) +114.08%
NTHI - NeOnc Technologies Holdings Inc - Stock Price Chart
TickerNTHI [NASD]
CompanyNeOnc Technologies Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap100.67MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-668.15%
Dividend-Sales Q/Q-
Insider Own79.15%Inst Own0.31%
Insider Trans0.16%Inst Trans0.09%
Short Float0.53%Earnings-
Analyst Recom-Target Price-
Avg Volume63.50K52W Range3.20 - 25.00
Jun-06-25 09:00AM NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs (GlobeNewswire)
Apr-15-25 08:05AM NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets (GlobeNewswire)
Apr-14-25 08:05AM NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September (GlobeNewswire) -12.06%
Apr-10-25 08:05AM NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President (GlobeNewswire) -10.00%
Apr-08-25 04:05PM NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy (GlobeNewswire)
Mar-31-25 08:05AM NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas (GlobeNewswire) -19.27%
Mar-28-25 11:15PM U.S. IPO Weekly Recap: CoreWeave Fails To Impress In Downsized IPO, As More Names Join The Pipeline (Seeking Alpha) +37.92%
Mar-27-25 08:05AM NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments (GlobeNewswire)
ANEB - Anebulo Pharmaceuticals Inc - Stock Price Chart
TickerANEB [NASD]
CompanyAnebulo Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap74.36MEPS (ttm)-0.27
P/E-EPS this Y10.94%
Forward P/E-EPS next Y-68.42%
PEG-EPS past 5Y-155.95%
P/S-EPS next 5Y-12.86%
P/B5.52EPS Q/Q36.05%
Dividend-Sales Q/Q-
Insider Own40.54%Inst Own55.05%
Insider Trans0.00%Inst Trans3.08%
Short Float0.14%EarningsMay 13/a
Analyst Recom1.00Target Price3.00
Avg Volume14.22K52W Range0.80 - 3.08
May-13-25 04:05PM Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire)
Feb-14-25 04:05PM Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire) +9.77%
Dec-24-24 09:25AM Anebulo Pharmaceuticals collaborates with FDA to advance selonabant (TipRanks) +29.60%
Dec-23-24 09:15AM Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise (Business Wire) +26.26%
Nov-13-24 04:05PM Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates (Business Wire) -6.06%
Sep-25-24 04:05PM Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates (Business Wire) -11.48% +5.95%
Jul-22-24 07:00AM Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects (Business Wire) +9.09%
Jul-01-24 08:00AM Lifecore Biomedical Announces Cooperation Agreement with 22NW (GlobeNewswire)
May-15-24 09:55PM ANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024 (InvestorPlace) -6.36%
01:05PM Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates (Business Wire)
CIGL - Concorde International Group Ltd - Stock Price Chart
TickerCIGL [NASD]
CompanyConcorde International Group Ltd
CountrySingapore
IndustrySecurity & Protection Services
Market Cap412.73MEPS (ttm)-5.08
P/E-EPS this Y-152.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S39.31EPS next 5Y-
P/B186.40EPS Q/Q-112.20%
Dividend-Sales Q/Q0.00%
Insider Own83.70%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.81%Earnings-
Analyst Recom-Target Price-
Avg Volume146.36K52W Range3.63 - 26.95
Jun-17-25 09:00AM Concorde International Group Secures SG$11.6 Million (Approx. US$9.0 Million) in New Multi-Year Recurring Revenue Contracts (GlobeNewswire)
May-16-25 08:00AM Concorde International Group Reports Full-Year 2024 Financial Results and Provides Business Update (GlobeNewswire) +8.85%
May-02-25 04:05PM Concorde International Group Announces Underwriters Full Exercise and Closing of Over-allotment Option (GlobeNewswire)
Apr-26-25 01:00AM U.S. IPO Weekly Recap: Small Foreign Issuers List In The U.S. As Notable IPOs Continue To Delay (Seeking Alpha)
Apr-23-25 11:25AM Concorde International Group Announces Closing of $5,000,000 Initial Public Offering (GlobeNewswire)
Apr-22-25 07:00AM Concorde International Group Announces Pricing of $5,000,000 Initial Public Offering (GlobeNewswire)
MOGO - Mogo Inc - Stock Price Chart
TickerMOGO [NASD]
CompanyMogo Inc
CountryCanada
IndustrySoftware - Infrastructure
Market Cap62.89MEPS (ttm)-0.65
P/E-EPS this Y-78.98%
Forward P/E-EPS next Y20.69%
PEG-EPS past 5Y15.64%
P/S1.23EPS next 5Y-
P/B1.30EPS Q/Q-209.58%
Dividend-Sales Q/Q-7.86%
Insider Own16.21%Inst Own10.78%
Insider Trans0.00%Inst Trans24.13%
Short Float1.26%EarningsMay 08/b
Analyst Recom1.50Target Price3.08
Avg Volume2.40M52W Range0.74 - 2.73
Jul-02-25 08:05AM Mogo Announces $50 Million Bitcoin Treasury Authorization and Strategic Alignment with Bitcoin Across the Organization (Business Wire) +112.40%
Jun-30-25 10:57PM Mogo Announces Results of its Annual General Meeting of Shareholders (Business Wire)
Jun-13-25 08:55PM Mogo Applies to Extend the Expiry Dates of Certain Warrants (Business Wire)
Jun-06-25 08:50AM Mogo (MOGO) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
May-21-25 08:50AM Here Is Why Bargain Hunters Would Love Fast-paced Mover Mogo (MOGO) (Zacks)
May-14-25 09:40AM Is Amplitude (AMPL) Outperforming Other Business Services Stocks This Year? (Zacks) -14.38%
08:50AM Robinhood Doubles Down on Crypto With WonderFi Buyout, Stock Jumps 9% (Zacks)
May-13-25 09:46AM Mogo Portfolio Company WonderFi Announces Definitive Agreement to be Acquired by Robinhood Markets (Business Wire) +53.52%
May-09-25 02:58PM Mogo to Participate in the D. Boral Capital Inaugural Global Conference (Business Wire) -6.42%
03:37AM Mogo Inc (MOGO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and AI Integration ... (GuruFocus.com)
CV - CapsoVision Inc - Stock Price Chart
TickerCV [NASD]
CompanyCapsoVision Inc
CountryUSA
IndustryMedical Devices
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume-52W Range- - -
Jul-01-25 09:08PM CapsoVision Announces Pricing of Initial Public Offering (GlobeNewswire)
123456⋯10⋯20
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.